The above results indicate that RBP-J OE Mφ-Exos probably play a potential regulation role in the glioma progression and circBTG2 could be a biomarker for glioma diagnosis and potential target for glioma therapy. This evidence concerns the gene RBPJ and central nervous system cancer.